Lithium Controlled-Release and Extended-Release Tablets and Naldemedine Tosylate
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Naldemedine Tosylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: naldemedine
Brand name: Symproic
Synonyms: Naldemedine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Nalex A 12
- Lithium Controlled-Release and Extended-Release Tablets-Nalex AC
- Lithium Controlled-Release and Extended-Release Tablets-Nalex-A
- Lithium Controlled-Release and Extended-Release Tablets-Nalfon
- Lithium Controlled-Release and Extended-Release Tablets-Nalfon 200
- Lithium Controlled-Release and Extended-Release Tablets-Nalfon Tablets
- Naldemedine Tosylate-Lithium ER
- Naldemedine Tosylate-Lithium Oral Solution
- Naldemedine Tosylate-Lithium Salts
- Naldemedine Tosylate-Lithium Syrup and Oral Solution
- Naldemedine Tosylate-Lithobid
- Naldemedine Tosylate-Lithostat